Home » Topics » Regulatory » Patents

Patents
RSS

Merck Frosst claims novel inhibitors of leukotriene biosynthesis

Feb. 16, 2005

New DPP-IV inhibitors for the treatment of NIDDM reported by Fujisawa

Feb. 16, 2005

New 5-HT receptor modulators claimed by Suven Life Sciences

Feb. 16, 2005

Genelabs Technologies presents novel antiviral agents

Feb. 16, 2005

Thrombopoietin receptor (TPOR) activators disclosed by Nissan Chemical

Feb. 16, 2005

Antibacterial prodrugs of 6-beta-hydroxymethylpenicillanic acid sulfone claimed in Pfizer patent

Feb. 16, 2005

New humanized anti-beta amyloid peptide monoclonal antibodies jointly reported by Neuralab and Wyeth

Feb. 15, 2005

Novel NMDA/NR2B antagonists discovered at Merck

Feb. 15, 2005

FibroGen claims new hypoxia-inducible factor (HIF) prolyl hydroxylase inhibitors

Feb. 15, 2005

Five series of Src tyrosine kinase inhibitors reported by AstraZeneca

Feb. 15, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026